Mankind Pharma Limited
Share Price Target & Analysis
NSE:MANKIND
VWAP
Open
Close
High
Low
52 Week High
-6.40 (-0.28%)
MANKIND
(PHARMA)Turnaround Potential
52 Week Low
EPS
PE
PB
Economical
Quality
Gold
Valuation
#Analysis
NSE: MANKIND Share Price Financial Analysis & Valuation
Mankind Pharma Limited (MANKIND) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals & Drugs vertical.
It is one of Large Cap company with Market Capitalization of Rs 0 (in Cr). Total number of free float shares are 0 (in Lacs).
Mankind Pharma Limited is listed on NSE with Exchange ID - INE634S01028 and trading code is NSE:MANKIND with short name Mankind Pharma.
In the past 1 year, Mankind Pharma Limited has declared an equity dividend of Rs 0.04 per share. At the current share price of MANKIND at Rs 2311.60, this results in a dividend yield of 0 %.
As per the Fundamental Analysis of NSE:MANKIND, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine MANKIND underlying value and future prospects. All of this data is available in MANKIND financial statements.
Quality of the Stock: As per the fundamental analysis of NSE:MANKIND, it is clearly understood that MANKIND is Economical performer in terms of earnings and profit margins with an EPS of 59.75. NSE:MANKIND book value per share as of today is 410.5. The current price to book ratio for MANKIND as of Sep 08, 2026 is 5.63.
Valuation of the Stock: The current valuation of MANKIND stock is like Gold which means currently the stock is Overpriced. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of MANKIND whether to BUY this stock at current valuation. The delivery percentage of MANKIND is 71012% is very crucial parameter which shows that 71012% investors are anticipating that the price of MANKIND share should go up with VWAP at 2315.9.
Now, the main question is whether to BUY or SELL, NSE:MANKIND at current valuation.
As per latest Analysis No. #3020:-
⇑ STRONG BUY MANKIND if All Greens
⇗ BUY MANKIND (at Lower Levels) if any 2 Greens
⇒ NEUTRAL or HOLD MANKIND (With Stop Loss) if only 1 Green
⇘ SELL MANKIND if NO Green Indicator
NSE: MANKIND Share Price Today (Sep 08, 2026)
(Mankind Pharma Limited Daily Analysis on the basis of MANKIND Intraday Graph & Trend)
Mankind Pharma Limited share price moved Down by -0.28% from its previous close of Rs 2318. MANKIND stock last traded price is 2311.60. MANKIND share price trend is Down with a total of 27312 stocks traded till now. It has touched an intraday high of Rs 2330.8 and an intraday low of Rs 2301. The MANKIND trading at 2311.60, Down by Rs. -6.40, or -0.28 percent which suggests that most of the Traders are anticipating that the price of MANKIND share should go Down.
NSE: MANKIND Share Price Tomorrow Prediction
(Mankind Pharma Limited Share Price Prediction for Tomorrow & future forecast is based on Current Trend of MANKIND)
Mankind Pharma Limited share price moved Down by -0.28%. MANKIND share price short term trend is Down. It suggests that MANKIND Share Price for Tomorrow remains the same with VWAP at 2315.9 will be treated as stop loss for intraday traders. Mankind Pharma Limited Long term investors can follow the MANKIND long term trend as mentiond in future forecast table.
NSE Code |
NSE: MANKIND |
MANKIND Share Price Today |
2311.60 |
MANKIND Share Price Target Prediction for 2026 ^ |
2201.5 - 2687.2 |
MANKIND Share Price Target Prediction for 2027*^ |
2687.2 - 2862.8 |
MANKIND Share Price Target Prediction for 2028*^ |
2862.8 - 3063.2 |
MANKIND Share Price Target Prediction for 2029*^ |
3216 |
MANKIND Share Price Target Prediction for 2030*^ |
3308 |
MANKIND Share Price Target Prediction for 2035*^ |
3606 |
| MANKIND Current Book Value |
408.4 |
*Mankind Pharma Limited Short Term & Long Term share price target is based on current financial year earings of the company.
^MANKIND share price target prediction for 2026 2027 2028 2029 2030 to 2035 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.
MANKIND Technical Analysis
Candlestick Pattern: @2356.5| MA | Simple | Action S1 | Expo | Action E2 |
|---|---|---|---|---|
| MA_5 | 2393.96 | SELL | 2385.72 | SELL |
| MA_12 | 2389.11 | SELL | 2397.53 | SELL |
| MA_20 | 2403.54 | SELL | 2411.56 | SELL |
| MA_32 | 2458.36 | SELL | 2429.41 | SELL |
| MA_50 | 2475.89 | SELL | 2431.31 | SELL |
| MA_100 | 2438.81 | SELL | 2405.46 | SELL |
| MA_200 | 2277.79 | BUY | 2366.21 | SELL |
| Trend Oscillators | Value | Action |
|---|---|---|
| Bollinger Bands | 2403.54 | Downtrend |
| MACD | 1.05 | BUY |
| ADX | 16.53 | NO or Weak Trend |
| DMI (+/-) | 15.15 / 21.05 | Downtrend |
| Momentum Oscillators | Value | Action |
|---|---|---|
| RSI | 40.51 | Neutral |
| STOCHASTIC_K (Fast) | 36.67 | Neutral |
| STOCHASTIC_D (Slow) | 63.25 | Neutral |
| CCI | -144.38 | SELL |
| PSAR | 2342.68 | BUY |
| TRUE RANGE | 69.2 | Neutral |
| ATR | 53.57 | Neutral |
| WILLIAMS R | -84.3 | Oversold |
| TRIX | 0 | Neutral |
| STOCHASTIC RSI K | 0 | Oversold |
| STOCHASTIC RSI D | 49.99 | Neutral |
| MOMENTUM | -126.5 | SELL |
| Duration | Value |
|---|---|
| 1 Year | -5.82% |
| 3 Months | 1.56% |
| 1 Month | -5.09% |
| 1 Week | -0.36% |
| Action | Overall (%) |
|---|---|
| BUY | 10% |
| NEUTRAL / HOLD | 27% |
| SELL | 63% |
Most popular Questions & Answers about MANKIND (/ FAQ MANKIND)
Mankind Pharma Limited stock last traded price is 2311.60. MANKIND share price moved Down by -0.28% from its previous close of Rs 2318.
Mankind Pharma Limited share price trend is Down with a total of 27312 stocks traded till now. It has touched an intraday high of Rs 2700.74 and an intraday low of Rs 2301. The MANKIND trading at 2311.60, Down by Rs. -6.40, or -0.28 percent which suggests that most of the Traders are anticipating that the price of MANKIND share should go Down and the Stop Loss will be around 2315.9.
The market cap of Mankind Pharma Limited is ₹0 (in Cr) as of Sep 07, 2026.
The current price to earning ratio for Mankind Pharma Limited as of Sep 07, 2026 is 43.79.
The current price to book ratio for Mankind Pharma Limited as of Sep 07, 2026 is 5.63.
The highest price of Mankind Pharma Limited stock is ₹2674 in the last 52-week.
The lowest price of Mankind Pharma Limited stock is ₹1909.7 in the last 52-week.
Mankind Pharma Limited share trading at ₹2311.60, Down by Rs. -6.40, or -0.28 percent which suggests that most of the traders are anticipating that the price of MANKIND share should go Down.
In 2026, Stock price target for Mankind Pharma Limited (MANKIND) will be around ₹2201.5 on downside and ₹2687.2 on upside. Mankind Pharma Limited share price target is based on current financial year earings of the company.
In 2027, Stock price target for Mankind Pharma Limited (MANKIND) will be around ₹2687.2 on downside and ₹2862.8 on upside. Mankind Pharma Limited share price target is based on forecasted future earnings of the company.
In 2028, Stock price target for Mankind Pharma Limited (MANKIND) will be around ₹2862.8 on downside and ₹3063.2 on upside. Mankind Pharma Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.
In next five years, Stock price target for Mankind Pharma Limited (MANKIND) will be around ₹3308 Mankind Pharma Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of MANKIND.
The price of Mankind Pharma Limited (MANKIND) shares moved by -0.28%. The short-term trend for MANKIND share price is Down. It implies that the share price of MANKIND will stay the same tomorrow and that intraday traders should treat VWAP at 2315.9 as a stop loss. Investors with a long-term outlook can track MANKIND long-term trajectory, which is indicated in the future forecast table.
Estimated DCF Value of MANKIND stock is 716.4. Compared to the current market price of 2311.60 INR, the MANKIND stock is Overvalued by 69%.
As per the fundamental analysis of Mankind Pharma Limited (MANKIND), it is of Economical quality in terms of earnings and profit margins with an EPS of 59.75. Mankind Pharma Limited book value per share as of today is 410.5. The current price to book ratio for MANKIND as of Sep 08, 2026 is 5.63.
NSE:MANKIND News & Other Useful Information about MANKIND Share Price
Peer Comparison of NSE: MANKIND
The Peers list includes companies operating in the same industry and having comparable market cap.
Sector: Pharmaceuticals & Drugs
| Company | Price | EPS | BV |
|---|---|---|---|
| ZYDUSLIFE | 1144.50 | 40.96 | 238.63 |
| GLAND | 2960.10 | 89.58 | 677.38 |
| CADILAHC | 1144.50 | 40.96 | 238.63 |
| MADHAVBAUG | 150.00 | 10.03 | 61.48 |
| SUVENPHAR | 376.20 | 11.05 | 115.25 |
| ERIS | 1327.40 | 29.16 | 234.07 |
| PGHL | 5601.50 | 211.15 | 373.93 |
| SYMBIOTEC | 1085.60 | 4.53 | 105.01 |
| GLS | 1350.20 | 49.12 | 284.45 |
| SUPRIYA | 904.60 | 29.51 | 151.81 |
| SIGACHI | 35.75 | -1.7 | 12.62 |
| SAKAR | 1178.95 | 24.29 | 150.48 |
| ORTINLAB | 14.93 | 0 | 1.11 |
| WALPAR | 23.05 | 2.55 | 18.08 |
| JSLL | 507.50 | 21.7 | 42.89 |
| JFLLIFE | 9.65 | 2.27 | 12.12 |
| MANKIND | 2311.60 | 59.75 | 410.5 |
| SOTAC | 90.05 | 6.71 | 52.33 |
| REMUS | 900.00 | 23.29 | 276.4 |
| VILINBIO | 59.75 | 1.57 | 18.6 |
| SAROJA | 38.95 | 0 | 43 |
| VALIANTLAB | 114.13 | 1.44 | 60.62 |
| BLUEJET | 569.05 | 15.67 | 82.91 |
| ACCENTMIC | 619.65 | 20.63 | 114.84 |
| ZENITHDRUG | 46.20 | 5.83 | 43.69 |
| INNOVACAP | 1165.00 | 21.16 | 160.54 |
| ENTERO | 1880.30 | 8.88 | 387.5 |
| EMCURE | 1932.40 | 51.69 | 206.16 |
| MEDIORG | 26.50 | -1.83 | 21.18 |
| AKUMS | 742.45 | 10.26 | 157.14 |